Literature DB >> 26799924

Philadelphia-positive dimorphic blasts in mixed-phenotype acute leukemia with TET2 mutation.

Preetesh Jain1, Guilin Tang2, Yang O Huh2, C Cameron Yin2, Zhuang Zuo2, Naveen Pemmaraju1, Zeev Estrov1, Naval Daver1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26799924      PMCID: PMC4870100          DOI: 10.1002/ajh.24295

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  5 in total

1.  A dimorphic blast population demonstrates Philadelphia-positive mixed phenotype acute leukaemia.

Authors:  Victoria Y Ling; Meaghan Wall; Amanda Davis; Malgorzata Gorniak; George Grigoriadis
Journal:  Pathology       Date:  2014-04       Impact factor: 5.306

2.  Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era.

Authors:  Hiroaki Shimizu; Akihiko Yokohama; Nahoko Hatsumi; Satoru Takada; Hiroshi Handa; Toru Sakura; Yoshihisa Nojima
Journal:  Eur J Haematol       Date:  2014-05-13       Impact factor: 2.997

3.  Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification.

Authors:  Lingzhi Yan; Nana Ping; Mingqing Zhu; Aining Sun; Yongquan Xue; Changgeng Ruan; Hans G Drexler; Roderick A F Macleod; Depei Wu; Suning Chen
Journal:  Haematologica       Date:  2012-05-11       Impact factor: 9.941

4.  (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible.

Authors:  Julie-Aurore Losman; Ryan E Looper; Peppi Koivunen; Sungwoo Lee; Rebekka K Schneider; Christine McMahon; Glenn S Cowley; David E Root; Benjamin L Ebert; William G Kaelin
Journal:  Science       Date:  2013-02-07       Impact factor: 47.728

5.  Mixed Phenotype Acute Leukemia with Two Immunophenotypically Distinct B and T Blasts Populations, Double Ph (+) Chromosome and Complex Karyotype: Report of an Unusual Case.

Authors:  Samah A Kohla; Ahmad Al Sabbagh; Halima El Omri; Firyal A Ibrahim; Ivone B Otazu; Hessa Alhajri; Mohamed A Yassin
Journal:  Clin Med Insights Blood Disord       Date:  2015-09-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.